Impa International Metabolic Physicians Association Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 22-12-2024
- Paid Up Capital ₹ 60.00 K
as on 22-12-2024
- Company Age 2 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
About Impa International Metabolic Physicians Association
The Company is engaged in the Non-Profit Organizations Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 60.00 K , as per Ministry of Corporate Affairs (MCA) records.
Neeta Deshpande, Nitin Patankar, Vimal Pahuja, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85300MH2022NPL381643
- Company No.
381643
- Company Classification
Private Not For Profit Company
- Incorporation Date
28 Apr 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Impa International Metabolic Physicians Association?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Patankar  | Director | 28-Apr-2022 | Current |
| Neeta Deshpande | Director | 26-Apr-2024 | Current |
| Vimal Pahuja | Director | 28-Apr-2022 | Current |
| Rajesh Patil | Director | 20-Jan-2024 | Current |
| Ketan Pakhale | Director | 21-Feb-2024 | Current |
| Nitin Kapoor | Director | 21-Feb-2024 | Current |
Financial Performance of Impa International Metabolic Physicians Association.
Enhance accessibility to Impa International Metabolic Physicians Association's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Impa International Metabolic Physicians Association?
Unlock access to Impa International Metabolic Physicians Association's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ndg-Sevasadan Super Speciality & Diabete S Hospital LlpActive 5 years 7 monthsNeeta Deshpande is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Impa International Metabolic Physicians Association?
Impa International Metabolic Physicians Association has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Impa International Metabolic Physicians Association, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Impa International Metabolic Physicians Association's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
